CYRABETA PLUS TABLET

Product Description

CYRABETA PLUS TABLET is a clinically trusted combination of Propranolol 40mg and Flunarizine 10mg, formulated for the effective prevention of migraine, management of hypertension, and treatment of vestibular disorders. This dual-action formulation works by reducing blood pressure and stabilizing vascular activity in the brain, helping prevent the frequency and intensity of migraine attacks.

Manufactured in WHO-GMP certified facilities, CYRABETA PLUS is widely recommended by neurologists and general physicians, making it a high-demand product for medical wholesalers, retailers, and bulk pharmaceutical buyers across India.

Key Benefits:

• Effective combination for migraine prophylaxis and hypertension control

• Propranolol: A beta-blocker that reduces heart rate and blood pressure

• Flunarizine: A calcium channel blocker that prevents cerebral vasospasms

• Suitable for long-term neurological care

Applications:

• Migraine prevention and vascular headache treatment

• Adjunct therapy in essential tremors and vertigo

• Useful in cardiovascular and neurological protocols

Ideal For:

• Distributors and stockists targeting neurology and general medicine segments

• Retail pharmacies and hospital supply chains

• Bulk procurement and PCD pharma franchise opportunities